Romania – Laboratory reagents – Acord cadru – Reactivi si consumabile de laborator – 12 loturi in cadrul proiectului PNRR "SysScleRO – Systems immunology for systemic sclerosis (SSc): assessment of innate immune memory and immune aging as basis for individualised prevention and treatment modalities in SSc" CF 82/31.07.2023, Contract de finanțare nr.760236/28.12.2023
Universitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca
Buyer country
Romania
Publication date
Not specified
Biderra sector
Health and medical
Data source
TED open data
Decision signals
First-pass opportunity review
These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.
- Timing signal
- Deadline not indexed
- Indexed data completeness
- 86%
- Official title coverage
- 7 languages
- Classification signal
- 33696500
Check the official notice
Based on seven decision fields
Preserved from source-supplied versions
Medical equipment, pharmaceuticals and personal care products
Official title versions
TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.
Rumanía – Reactivos de laboratorio – Acord cadru – Reactivi si consumabile de laborator – 12 loturi in cadrul proiectului PNRR "SysScleRO – Systems immunology for systemic sclerosis (SSc): assessment of innate immune memory and immune aging as basis for individualised prevention and treatment modalities in SSc" CF 82/31.07.2023, Contract de finanțare nr.760236/28.12.2023
Roemenië – Laboratoriumreagentia – Acord cadru – Reactivi si consumabile de laborator – 12 loturi in cadrul proiectului PNRR "SysScleRO – Systems immunology for systemic sclerosis (SSc): assessment of innate immune memory and immune aging as basis for individualised prevention and treatment modalities in SSc" CF 82/31.07.2023, Contract de finanțare nr.760236/28.12.2023
Rumunia – Odczynniki laboratoryjne – Acord cadru – Reactivi si consumabile de laborator – 12 loturi in cadrul proiectului PNRR "SysScleRO – Systems immunology for systemic sclerosis (SSc): assessment of innate immune memory and immune aging as basis for individualised prevention and treatment modalities in SSc" CF 82/31.07.2023, Contract de finanțare nr.760236/28.12.2023
Roumanie – Réactifs de laboratoire – Acord cadru – Reactivi si consumabile de laborator – 12 loturi in cadrul proiectului PNRR "SysScleRO – Systems immunology for systemic sclerosis (SSc): assessment of innate immune memory and immune aging as basis for individualised prevention and treatment modalities in SSc" CF 82/31.07.2023, Contract de finanțare nr.760236/28.12.2023
Rumänien – Laborreagenzien – Acord cadru – Reactivi si consumabile de laborator – 12 loturi in cadrul proiectului PNRR "SysScleRO – Systems immunology for systemic sclerosis (SSc): assessment of innate immune memory and immune aging as basis for individualised prevention and treatment modalities in SSc" CF 82/31.07.2023, Contract de finanțare nr.760236/28.12.2023
Romania – Reattivi per laboratorio – Acord cadru – Reactivi si consumabile de laborator – 12 loturi in cadrul proiectului PNRR "SysScleRO – Systems immunology for systemic sclerosis (SSc): assessment of innate immune memory and immune aging as basis for individualised prevention and treatment modalities in SSc" CF 82/31.07.2023, Contract de finanțare nr.760236/28.12.2023
Romania – Laboratory reagents – Acord cadru – Reactivi si consumabile de laborator – 12 loturi in cadrul proiectului PNRR "SysScleRO – Systems immunology for systemic sclerosis (SSc): assessment of innate immune memory and immune aging as basis for individualised prevention and treatment modalities in SSc" CF 82/31.07.2023, Contract de finanțare nr.760236/28.12.2023
What Biderra adds
For notice 477973-2026, Biderra has normalized the contracting authority country as Romania, grouped CPV 33696500 under health and medical, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.